Paying users zone. Data is hidden behind: .
Get 1-month access to Vertex Pharmaceuticals Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Vertex Pharmaceuticals Inc. pages available today for free:
Analysis of Debt
Total Debt (Carrying Amount)
Vertex Pharmaceuticals Inc., balance sheet: debt
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
| Debt item | Description | The company |
|---|---|---|
| Total long-term obligations (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Vertex Pharmaceuticals Inc.’s total debt increased from 2017 to 2018 but then decreased significantly from 2018 to 2019. |
Total Debt (Fair Value)
| Dec 31, 2019 | |
|---|---|
| Selected Financial Data (US$ in thousands) | |
| Current finance lease liabilities | |
| Long-term finance lease liabilities | |
| Credit facility | |
| Senior secured term loan, including current portion | |
| Total long-term obligations (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (filing date: 2020-02-13).
Weighted-average Interest Rate on Debt
Weighted-average discount rate, finance leases:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (filing date: 2020-02-13).
1 US$ in thousands
2 Weighted-average interest rate = 100 × ÷ =